• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Planning for a Pandemic/Epidemic or Disaster
Planning for a Pandemic/Epidemic or Disaster

Descriptive Epidemiology Dr. KANUPRIYA CHATURVEDI
Descriptive Epidemiology Dr. KANUPRIYA CHATURVEDI

Slide 1
Slide 1

Cognitive Disorders
Cognitive Disorders

Session 2. Synaptic Plasticity (Chair, H. Kamiguchi)
Session 2. Synaptic Plasticity (Chair, H. Kamiguchi)

Assessment and management of dementia in
Assessment and management of dementia in

Special Seminar in Neuroscience  Alterations in the Cortical Connectome
Special Seminar in Neuroscience Alterations in the Cortical Connectome

What evidence there is for the drug treatment of Huntington`s disease
What evidence there is for the drug treatment of Huntington`s disease

... to be poorly tolerated due to dystonia and parkinsonism.4 Atypical antipsychotics tend to be used at this point although the evidence to support their efficacy and tolerability is also limited to case reports and series. Meco et al18 compared risperidone with haloperidol in three patients with HD an ...
The Neuron: The Basic Unit of Communication Neuron: Basic
The Neuron: The Basic Unit of Communication Neuron: Basic

Neuropsychology of Parkinson`s Communication Problems
Neuropsychology of Parkinson`s Communication Problems

Importance of communication of physiotherapists working with
Importance of communication of physiotherapists working with

neurological syndromes which can be mistaken for
neurological syndromes which can be mistaken for

DELIRIUM, DEMENTIA, DEPRESSION AND COMPETENCY
DELIRIUM, DEMENTIA, DEPRESSION AND COMPETENCY

Neurology_Review_MKSAP
Neurology_Review_MKSAP

Rheumatoid_Arthritis_Resident_Lecture
Rheumatoid_Arthritis_Resident_Lecture

James R. Hall, Ph.D., FACMPP, FICPP (Geriatrics)
James R. Hall, Ph.D., FACMPP, FICPP (Geriatrics)

Dramatic Response of Parkinsonism to a Vegan Diet: Case Report
Dramatic Response of Parkinsonism to a Vegan Diet: Case Report

Dopamine transporter SPECT imaging
Dopamine transporter SPECT imaging

Cholinesterase Inhibitors for Alzheimer`s
Cholinesterase Inhibitors for Alzheimer`s

Snímek 1
Snímek 1

Chapter13Lecture
Chapter13Lecture

Glossary of medical and scientific terms
Glossary of medical and scientific terms

... The transmission of an illness from the parent(s) to the offspring. Virus A infective agent with a specific structure and able to cause its own multiplication after infection of specific cells. VPSPr Variably protease sensitive prionopathy (VPSPr) is a relatively newly described (in 2008) human prio ...
學系別
學系別

Neuroscience-Alzheimer`s products (, 1.78 kB)
Neuroscience-Alzheimer`s products (, 1.78 kB)

Fact Sheet  Coats’ Disease 
Fact Sheet Coats’ Disease 

< 1 ... 26 27 28 29 30 31 32 33 34 ... 47 >

Alzheimer's disease



Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD. There are no medications or supplements that decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programs are beneficial with respect to activities of daily living and can potentially improve outcomes. Treatment of behavioral problems or psychosis due to dementia with antipsychotics is common but not usually recommended due to there often being little benefit and an increased risk of early death.In 2010, there were between 21 and 35 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2010, dementia resulted in about 486,000 deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report